35
Participants
Start Date
June 30, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
April 30, 2014
Sorafenib
Tablet, 400mg orally, twice daily
SIR-Spheres
one time treatment and capped at 3.0 Gbq
Singapore General Hospital, Singapore
National Cancer Centre, Singapore
Yangon GI & Liver Centre, Yangon
Selayang Hospital, Kuala Selangor
Seoul National University Bundang Hospital, Seoul
Collaborators (1)
National Medical Research Council (NMRC), Singapore
OTHER_GOV
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
INDUSTRY
Sirtex Medical
INDUSTRY
Singapore Clinical Research Institute
OTHER